Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
2,436
-506
-17% -$59.2K 0.15% 44
2026
Q1
$354K Sell
2,942
-10
-0.3% -$1.15K 0.18% 44
2025
Q4
$311K Hold
2,952
0.13% 50
2025
Q3
$248K Buy
2,952
+510
+21% +$42K 0.13% 42
2025
Q2
$219K Hold
2,442
0.13% 46
2025
Q1
$219K Buy
2,442
+101
+4% +$9.43K 0.13% 46
2024
Q4
$234K Buy
+2,341
New +$241K 0.13% 46

Other funds holding MRK

Banque de Luxembourg's MRK Position: Q2 2026 in Review

Banque de Luxembourg reduced its Merck (MRK) stake by 17% in Q2 2026, selling an estimated $59.2K and leaving 2,436 shares worth $313K. The position accounts for 0.15% of the portfolio, ranked #44.

Banque de Luxembourg first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $354K in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Banque de Luxembourg held 2,436 shares of Merck worth $313K as of Q2 2026.
  • Banque de Luxembourg sold 506 Merck shares in Q2 2026, an estimated $59.2K.
  • Merck made up 0.15% of Banque de Luxembourg's portfolio in Q2 2026, its #44 holding.
  • Banque de Luxembourg first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Banque de Luxembourg's Merck position peaked at $354K in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Banque de Luxembourg's 13F filing for Q2 2026, filed 9 Jul 2026.